A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute stemi patients undergoing primary PCI
Keyword(s):
1988 ◽
Vol 23
(sup148)
◽
pp. 29-37
◽
2014 ◽
Vol 63
(12)
◽
pp. A207
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2007 ◽
Vol 57
(6)
◽
pp. 501
Keyword(s):